Send inquiry
Model Number: QQM67-#0729
Brand Name: QQM
Key Specifications/Special Features:
Edoxaban (DU-176b, trade names Savaysa, Lixiana) is an oral anticoagulant drug which acts as direct factor Xa inhibitorIt was developed by Daiichi Sankyo and approved in July 2011 in Japan for prevention of venous thromboembolisms (VTE) following lower-limb orthopedic surgery[1] It was also approved by FDA in January 2015 for the prevention of stroke and non–central-nervous-system systemic embolism4-CEC,4CLPVP,BK-EBDP,APPP,MDPHP,5FADB,ADB-F,5F-MN24,FUB-AMB,MMB-FUBINACA,2-NMC,MDPT,4-CDC,4-EMC,4CL-PET,MD-PHP,THPVP,MMBC,Dibutylone,5FSDB005,4CL-PMT,4F-MPH,4MPD,FMXP,BMDP,4CPRC,HEX-EN4FPHPMDMB2201, 5FMDMB2201,Furanylfentanyl,GEFITINIB,IBRUTINIB, ERLOTINIB2-A1MPU-47700, U49900, Mexedrone, Etizolam, 3FPM, Isopropylphenidate, 4FIBF
Shipping Information:
- FOB Port: Hong Kong Shanghai
- Lead Time: 3 - 7 days
- Weight per Unit: 1.5 Kilograms
- Units per Export Carton: 1000
- Export Carton Dimensions L/W/H: 30 × 0.5 × 40 Centimeters
- Export Carton Weight: 1.5 Kilograms
Main Export Markets:
- Eastern Europe
- North America